sr141716 has been researched along with Anterior Choroidal Artery Infarction in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Egashira, N; Fujioka, M; Fujiwara, M; Harada, K; Hayakawa, K; Hazekawa, M; Iwasaki, K; Mishima, K; Mishima, S; Nozako, M; Ogata, A; Orito, K | 1 |
| Abe, K; Egashira, N; Fujioka, M; Fujiwara, M; Hasebe, N; Hayakawa, K; Hazekawa, M; Iwasaki, K; Liu, AX; Mishima, K; Nozako, M; Ogata, A | 1 |
2 other study(ies) available for sr141716 and Anterior Choroidal Artery Infarction
| Article | Year |
|---|---|
Delta9-tetrahydrocannabinol (Delta9-THC) prevents cerebral infarction via hypothalamic-independent hypothermia.
Topics: Analysis of Variance; Animals; Blotting, Western; Body Temperature; Body Temperature Regulation; Cerebral Cortex; Cerebral Infarction; Dronabinol; Electrophoresis, Polyacrylamide Gel; Gene Expression Regulation; Hypothermia, Induced; Male; Mice; Piperidines; Pyrazoles; Rimonabant; Tetrazolium Salts | 2007 |
Repeated treatment with cannabidiol but not Delta9-tetrahydrocannabinol has a neuroprotective effect without the development of tolerance.
Topics: Analysis of Variance; Animals; Behavior, Animal; Body Temperature; Cannabidiol; Cerebral Infarction; Cerebrovascular Circulation; Dose-Response Relationship, Drug; Dronabinol; Drug Administration Schedule; Drug Interactions; Drug Tolerance; Infarction, Middle Cerebral Artery; Male; Mice; Neuroprotective Agents; Piperazines; Piperidines; Pyrazoles; Rimonabant; Serotonin Antagonists; Time Factors | 2007 |